<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Immunological Research (NK Cells) | IRFF Genome Institute</title>
    <meta name="description" content="Explore our immunological research focusing on Natural Killer (NK) cells, their role in immune function, and potential therapeutic applications in cancer and infectious diseases.">

    <!-- Link to CSS -->
    <link rel="stylesheet" href="css/style.css">
    <!-- Google Fonts and Font Awesome -->
    <link href="https://fonts.googleapis.com/css2?family=Roboto&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css" integrity="sha512-Fo3rlrZj/k7ujTnHg4C+XH3iwxYV5lB6XxJY2OvM0nG5Xh9D+J5m6cUO8zjNk9PvsxOvfN54P9B8hK9e+xkHg==" crossorigin="anonymous" referrerpolicy="no-referrer" />
</head>
<body>
    <div class="header-banner">
        Institute of Rheological Functions of Food (IRFF)
    </div>    
    <!-- Header Section -->
    <header>
        <div class="container">
            <div class="logo">
                <a href="index.html"><img src="images/logo.png" alt="Institute Logo"></a>
            </div>
            <nav>
                <ul class="nav-menu">
                    <li><a href="index.html">Home</a></li>
                    <li><a href="about.html">About Us</a></li>
                    <li><a href="research.html" class="active">Research</a></li>
                    <li><a href="collaborations.html">Collaborations</a></li>
                    <li><a href="news.html">News</a></li>
                    <li><a href="publications.html">Publications</a></li>
                    <li><a href="healthproduct.html">Health Product</a></li> <!-- New Menu Item -->
                    <li><a href="innovation.html">Innovation</a></li> <!-- New Menu Item -->
                    <li><a href="contact.html">Contact Us</a></li>
                </ul>
            </nav>
            <!-- Hamburger Menu for Mobile -->
            <button class="hamburger" aria-label="Toggle navigation" aria-expanded="false">
                <i class="fas fa-bars"></i>
            </button>
        </div>
    </header>

    <!-- Research Topic Section -->
    <section class="research-topic">
        <div class="container">
            <h1>Immunological Research (NK Cells)</h1>
            <div class="section-spacing"></div>
            <p>Our Immunological Research focuses on Natural Killer (NK) cells, key components of the innate immune system. We investigate their roles in combating cancer and infectious diseases, aiming to develop NK cell-based therapies for enhanced immune responses.</p>
            
            <!-- Placeholder for Detailed Content -->
            <div class="gallery">
                <a href="images/immunology_research1.png" data-lightbox="immunological-research" data-title="Immunological Research 1">
                    <img src="images/immunology_research1.png" alt="Immunological Research 1">
                </a>
                <!-- Add more images as needed -->
            </div>
            <div class="content-placeholder">
                <p>Immunological Research Report: Plasmalogen-Mediated Activation of GPCR21 in NK Cells

                    <br><b>Overview of Research</b> Our recent study, published in the Journal of Immunology (2022), has unveiled a groundbreaking mechanism highlighting the role of plasmalogens (Pls) in immune cell function. This research establishes that Pls, a unique class of phospholipids, play a pivotal role in regulating the cytolytic activity of natural killer (NK) cells through the activation of G protein-coupled receptor 21 (GPCR21). The findings of this study shed light on a previously elusive aspect of aging-related immune deficiency, providing insights that could revolutionize our understanding of immune system functionality in the elderly.
                    
                    <br><b>Key Findings</b> Role of Plasmalogens: Pls were identified as essential for the activation of NK cells, with their levels found to be significantly reduced in the elderly population.
                    
                    Activation of GPCR21: Our study pinpointed the extracellular glycosylation site of GPCR21 as a critical factor for NK cell activation via Pls.
                    
                    STAT5-Dependent Mechanism: The Pls-GPCR21 signaling pathway activates the transcription factor STAT5, which upregulates Perforin-1, a key cytolytic protein required for NK cell-mediated cytotoxicity.
                    
                    Therapeutic Potential: Oral ingestion of Pls demonstrated significant anti-cancer effects in SCID mice and reduced the systemic spread of murine CMV in C57BL/6J mice.
                    
                    <br><b>Importance of the Study</b> Addressing Aging-Related Immune Deficiency: This study provides a critical understanding of how reduced Pls levels contribute to immune decline in aging. This is vital for designing interventions to boost immunity among the elderly.
                    
                    Enhancing Cancer Immunotherapy: By elucidating the Pls-GPCR21 pathway, our findings open new avenues for augmenting NK cell activity in cancer therapy.
                    
                    Combating Viral Infections: The ability of Pls to enhance NK cell response against viral infections such as murine CMV underscores its potential in addressing immune deficiencies in various clinical settings.
                    
                    Innovative Therapeutics: Our results suggest that Pls supplementation could be a novel therapeutic strategy for improving NK cell function and combating age-related diseases.
                    
                    <br><b>Future Directions</b> Clinical Trials in Humans: Building on these preclinical findings, we aim to initiate clinical trials to evaluate the efficacy of Pls supplementation in improving immune function and combating cancer in elderly patients.
                    
                    Exploration of GPCR21 Mechanisms: Further research is required to explore the structural and functional nuances of GPCR21, including its glycosylation sites and interaction with Pls.
                    
                    Broad-Spectrum Applications: Expanding the study to investigate the role of Pls-GPCR21 signaling in other immune cells and diseases, including autoimmune disorders.
                    
                    Development of Synthetic Plasmalogens: Research into synthetic analogs of Pls could provide more stable and efficient therapeutic options for enhancing immune response.
                    
                    Targeted Drug Delivery Systems: Leveraging GPCR21â€™s specific role in NK cells, we aim to develop targeted therapies that enhance immune function without systemic side effects.
                    
                    <br><b>Conclusion</b>This study underscores the significance of Pls-GPCR21 signaling in maintaining robust NK cell functionality and highlights the therapeutic potential of Pls in addressing age-related immune decline, cancer, and viral infections. By advancing this research, our team is committed to pioneering innovative solutions to enhance immune health and improve quality of life, particularly in aging populations.
                    
                    <br><b>Acknowledgments</b> We extend our gratitude to our collaborators, research institutions, and funding agencies for their support in making this study possible.</p>
            </div>

            
        </div>
    </section>
    <div class="section-spacing-large"></div>

    <!-- Footer Section -->
    <footer>
        <div class="container">
            <div class="footer-links">
                <a href="privacy.html">Privacy Policy</a>
                <a href="terms.html">Terms of Service</a>
            </div>
            <div class="social-media">
                <a href="https://facebook.com" aria-label="Facebook" target="_blank"><i class="fab fa-facebook-f"></i></a>
                <a href="https://twitter.com" aria-label="Twitter" target="_blank"><i class="fab fa-twitter"></i></a>
                <a href="https://linkedin.com" aria-label="LinkedIn" target="_blank"><i class="fab fa-linkedin-in"></i></a>
            </div>
            <div class="newsletter">
                <form id="newsletter-form">
                    <input type="email" name="email" placeholder="Subscribe to our newsletter" required aria-label="Email Address">
                    <button type="submit" aria-label="Subscribe">Subscribe</button>
                </form>
            </div>
            <p>&copy; IRFF Center for Genomic & Neural Innovation. All rights reserved.</p>
        </div>
    </footer>

    <!-- Modal Structure (for News & Events) -->
    <div id="modal" class="modal" aria-hidden="true">
        <div class="modal-content" role="dialog" aria-modal="true" aria-labelledby="modal-title">
            <button class="close-button" aria-label="Close Modal">&times;</button>
            <h2 id="modal-title">Modal Title</h2>
            <p id="modal-body">Modal content goes here.</p>
        </div>
    </div>

    <!-- Link to JavaScript -->
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <script src="js/script.js"></script>
</body>
</html>

